Lumen Gentium (The Light of Nations), the Vatican II constitution on the Church, marks its 60th anniversary Nov. 21. As a “dogmatic constitution” of an ecumenical council, it is officially one of the ...

VILLA GUARDIA, Italy, March 1 /PRNewswire-FirstCall/ -- Gentium S.p.A. (Nasdaq:GENT - News) today announced management and corporate restructuring changes resulting ...

As Jazz Pharmaceuticals ($JAZZ) rolls on with an orphan drug deal spree, shareholders of Gentium ($GENT), its latest target, are suing to stop the acquisition, saying ...

Lumen Gentium (Light of the Nations), the Second Vatican Council’s dogmatic constitution on the Church, celebrates its golden anniversary on Nov. 21 and is no less relevant today than when it was ...

The CHMP had issued the negative opinion in Mar 2013. Gentium is looking to get the candidate approved for treating and preventing hepatic veno-occlusive disease (VOD) in adults and children ...

Jazz Pharmaceuticals ( JAZZ) has entered into a definitive agreement to acquire biopharma company Gentium ( GENT) for $57.00 per share in cash or $1 billion. The offer price of $57.00 per share ...

Italy's Gentium has suffered a major setback after it emerged that the European Medicines Agency is likely to turn down defibrotide, its investigational treatment for hepatic veno-occlusive disease.

Gentium is looking to get the candidate approved for treating and preventing hepatic veno-occlusive disease (VOD) in adults and children. The condition appears in patients undergoing hematopoietic ...

Pope Paul VI presides over a 1963 session of Vatican II. Credit: CNS photo/Catholic Press Photo. The constitution, wrote America associate editor Donald R. Campion, S.J., shortly after its publication ...

Jazz Pharmaceuticals Plc, the maker of the narcolepsy treatment Xyrem, agreed to buy Gentium SpA, a rare-disease drug developer, in a deal valued at $1 billion. Jazz, based in Dublin, will pay $57 a ...

Gentium receives marketing authorization for Defitelio (R) for the treatment of severe hepatic veno-occlusive disease. Gentium S.p.A. has reported that the European Commission has granted a marketing ...

(Reuters) - Ireland-based Jazz Pharmaceuticals Plc said it would buy Italian biotech company Gentium S.p.A. for about $1 billion to get access to its lead product candidate, Defitelio, a drug used for ...